Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for BNKK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 27.52M
March 31, 2026 33.28M
December 31, 2025 35.00M
September 30, 2025 75.52M
June 30, 2025 23.09M
March 31, 2025 -0.5426M
December 31, 2024 -2.173M
September 30, 2024 6.378M
June 30, 2024 6.470M
March 31, 2024 5.570M
December 31, 2023 8.817M
September 30, 2023 6.709M
June 30, 2023 5.668M
March 31, 2023 5.808M
Date Value
December 31, 2022 3.666M
September 30, 2022 8.557M
June 30, 2022 10.70M
March 31, 2022 11.65M
December 31, 2021 16.60M
September 30, 2021 29.63M
June 30, 2021 3.717M
March 31, 2021 4.431M
December 31, 2020 4.394M
September 30, 2020 -0.791M
June 30, 2020 -0.3322M
March 31, 2020 0.1012M
December 31, 2019 0.3792M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
BioForce Nanosciences Holdings, Inc. 2.303M
Skinhealth Systems, Inc. 55.57M
Evercore Holdings, Inc. -2.499M
DND Technologies, Inc. -2.113M
CCA Industries, Inc. 3.505M

Shareholders Equity (Quarterly) Related Metrics